In this animation, the role of the renin-angiotensin system (RAS) beyond hypertension is explored outlining how it impacts end-organ damage.
Review some of the underlying data and the impact ARBs can have in these patients in this animation produced by Novartis.
This Novartis-produced animation explores the advantages of an intensive therapeutic strategy to achieve blood pressure control.
Watch this Novartis-produced overview of the benefits that a single-pill combination therapy can have for your patients’ blood pressure control and treatment adherence.
Alternatively login via
Back to epgonline.org